4
Changes in Ownership
InspireMD, Inc. Filed Acc 0001493152-26-024864
Chief Commercial Officer sold 85,295 shares at an average $2.22 ($189,594)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gleason Shane Thomas Chief Commercial Officer | 2025-01-27 | Sale | −3,858 | $2.71 | $10,455 | 1,135,319 | D: show line 1 in the form |
| Gleason Shane Thomas Chief Commercial Officer | 2025-01-28 | Sale | −2,476 | $2.61 | $6,462 | 1,132,843 | D: show line 2 in the form |
| Gleason Shane Thomas Chief Commercial Officer | 2025-01-29 | Sale | −3,660 | $2.46 | $9,004 | 1,129,183 | D: show line 3 in the form |
| Gleason Shane Thomas Chief Commercial Officer | 2025-01-30 | Sale | −2,454 | $2.51 | $6,160 | 1,126,729 | D: show line 4 in the form |
| Gleason Shane Thomas Chief Commercial Officer | 2025-01-31 | Sale | −9,923 | $2.55 | $25,304 | 1,116,806 | D: show line 5 in the form |
| Gleason Shane Thomas Chief Commercial Officer | 2025-02-03 | Sale | −7,073 | $2.51 | $17,753 | 1,109,733 | D: show line 6 in the form |
| Gleason Shane Thomas Chief Commercial Officer | 2025-02-04 | Sale | −5,132 | $2.46 | $12,625 | 1,104,601 | D: show line 7 in the form |
| Gleason Shane Thomas Chief Commercial Officer | 2025-02-25 | Sale | −10,000 | $3.65 | $36,500 | 1,094,601 | D: show line 8 in the form |
| Open-market sales · 85,295 sh · avg $2.22 · $189,594 | |||||||
Loading xslF345X06/ownership.xml…